New Molecular Testing CPT Codes Offer Clarity for Payers and Providers

Posted by The Evidence Blog on February 23, 2012

by Diane Allingham-Hawkins, PhD, FCCMG, FACMG, Director, Genetic Test Evaluation Services 

If you encounter CPT codes at all in your work, you should be aware that the first series of new CPT codes for molecular testing went into effect on January 1, 2012. In our opinion, that’s a good thing, since the new CPT codes provide payers and providers with clarity regarding the type of testing being requested and/or performed.

So that our clients can make informed decisions about managing and paying for these molecular tests, we’ve posted initial reviews of the evidence for the diseases and tests associated with all of the 193 newly implemented codes. We’ve also created a new section on our website that lists all available GTE topics that correspond with these new CPT codes. If you’re already a Hayes’ GTE client, you can access all of our evidence reviews through the Knowledge Center. If you’re not a Hayes’ GTE client, you can download a sample GTE report here after completing a short registration form. You can also purchase any of our reports individually. Contact us for more information.

We’ll be adding full health technology assessments throughout the year for those topics with sufficient evidence, so check back frequently for updates.

And, if you’re confused about how to navigate the new CPT coding landscape, we’ve planned a live webinar for March 20, 2012. Click here to find more information about the webinar and to register.

Topics: Payers, Hayes Blog, Genetic Testing

Sign up to receive updates from our blog

Our latest articles

New Call-to-action